Wirtschafts-Deal des Jahres - Der Mann, der es tat – Jean-Paul Clozel verkaufte seine Actelion: «Manchmal packt mich Wehmut»
PharmaBoardroom - Jean-Paul Clozel - CEO, Idorsia (October 2017)
Team Actelion. In the 1980s, hundreds of biotechnology… | by Life Sciences at CHF | LSF Magazine | Medium
Jean-Paul Clozel | EY - Global
Actelion: independent thinking | Financial Times
Der Actelion-Gründer hat alle seine Ziele erreicht – und beginnt von vorn | NZZ
Jean-Paul Clozel
Startup Guide - Jean-Paul and Martine Clozel are... | Facebook
Was plant das Ehepaar Clozel? | NZZ
Actelion's Jean-Paul Clozel aims to keep group's independence | Financial Times
Jean-Paul Clozel: «Idorsia steht nicht zum Verkauf» | Finanz und Wirtschaft
Profile: Jean-Paul Clozel | Nature Biotechnology
Actelion offers sweetener to stave off attacks - SWI swissinfo.ch
Big Boss - Jean-Paul Clozel | TV5MONDE Europe
Jean-Paul Clozel, patron de l'entreprise de biotechnologie Actelion - RTS.ch
Actelion CEO and co-founder Jean-Paul Clozel gives a press conference... Foto di attualità - Getty Images
Actelion CEO Becomes a Billionaire With J&J's Bid for Drugmaker - Bloomberg
Jean-Paul Clozel - CEO @ Idorsia - Crunchbase Person Profile
Jean-Paul Clozel – mit Herzblut für Actelion - Rendez-vous - SRF
Les secrets de management de Jean-Paul Clozel, l'homme qui a vendu sa biotech 30 milliards - Challenges
We could be the 1st EU-Biopharma entering the Major League"
Actelion Chief Executive Officer Jean-Paul Clozel poses at the Forbes... News Photo - Getty Images
Jean-Paul Clozel, co-founder of Actelion Ltd., speaks during a news... News Photo - Getty Images
Swiss biotech group Actelion CEO Jean-Paul Clozel arrives for his company's annual general meeting in Basel, May 5, 2011. REUTERS/Christian Hartmann (SWITZERLAND - Tags: BUSINESS HEALTH Stock Photo - Alamy
J&J seals $30bn Swiss Actelion deal | The Peninsula Qatar
How is Actelion Spin-Off Idorsia Doing One Year Later?
Molecular Millionaire: Jean-Paul Clozel of Actelion
